⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10516990 | 0.86 | — | — | |
| SCHEMBL18207922 | 0.84 | — | — | |
| SCHEMBL16877775 | 0.81 | — | — | |
| SCHEMBL16878021 | 0.80 | — | — | |
| SCHEMBL55925 | 0.74 | — | — | |
| SCHEMBL9675320 | 0.74 | — | — | |
| SCHEMBL18207511 | 0.69 | — | — | |
| SCHEMBL16877794 | 0.67 | — | — | |
| Ammonia Solution, Strong SCHEMBL1894154 | 0.67 | — | — | |
| SCHEMBL16877981 | 0.67 | TTR (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111171245-B | Preparation method and application of acrylate compound for slump-retaining type polycarboxylate superplasticizer | 安徽海螺新材料科技有限公司 | 2022-08-02 | — | — | CN | claimed |
| US-20230295178-A1 | SUBSTITUTED FURANOPYRIMIDINE COMPOUNDS AS PDE1 INHIBITORS | DART NEUROSCIENCE LLC (US) | 2023-09-21 | — | — | US | disclosed |
| CN-111171245-B | Preparation method and application of acrylate compound for slump-retaining type polycarboxylate superplasticizer | 安徽海螺新材料科技有限公司 | 2022-08-02 | — | — | CN | disclosed |
| EP-3717488-B1 | SUBSTITUTED FURANOPYRIMIDINE COMPOUNDS AS PDE1 INHIBITORS | DART NEUROSCIENCE LLC (US) | 2021-09-29 | — | — | EP | disclosed |
| WO-2019104285-A1 | SUBSTITUTED FURANOPYRIMIDINE COMPOUNDS AS PDE1 INHIBITORS | DART NEUROSCIENCE, LLC (US) | 2019-05-31 | — | — | WO | disclosed |
| US-20160326157-A1 | MONOBACTAMS AND METHODS OF THEIR SYNTHESIS AND USE | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2016-11-10 | — | — | US | disclosed |
| WO-2015103583-A1 | MONOBACTAMS AND METHODS OF THEIR SYNTHESIS AND USE | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2015-07-09 | — | — | WO | disclosed |
| WO-2011060000-A1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2011-05-19 | — | — | WO | disclosed |
| EP-0039595-B1 | TOTAL SYNTHESIS OF 1RS,4SR,5RS-4-(4,8-DIMETHYL-5-HYDROXY-7-NONEN-1-YL)-4-METHYL-3,8-DIOXABICYCLO(3.2.1)OCTANE-1-ACETIC ACID AND RELATED COMPOUNDS | ORTHO PHARMACEUTICAL CORPORATION (US) | 1985-03-27 | — | — | EP | disclosed |
| EP-0021775-B1 | SYNTHESIS OF 1RS,4SR,5RS-4-(4,8-DIMETHYL-5-HYDROXY-7-NONEN-1-YL)-4-METHYL-3,8-DIOXABICYCLO(3.2.1)OCTANE-1-ACETIC ACID AND INTERMEDIATES | ORTHO PHARMACEUTICAL CORPORATION (US) | 1984-09-26 | — | — | EP | disclosed |